Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011-2017: A Retrospective Cohort Study (Korean TB-POST).
Hongjo ChoiJeong Ha MokYoung Ae KangDawoon JeongHee-Yeon KangHee Jin KimHee-Sun KimDoo Soo JeonPublished in: Journal of Korean medical science (2023)
The treatment outcomes of patients with MDR/RR-TB has gradually improved but increasing deaths during treatment is an emerging challenge for MDR-TB control in Korea. Targeted and comprehensive care is needed for vulnerable patients such as the elderly, patients with comorbidities, and those with low household incomes.
Keyphrases
- mycobacterium tuberculosis
- end stage renal disease
- multidrug resistant
- healthcare
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- palliative care
- drug resistant
- pulmonary tuberculosis
- quality improvement
- hiv aids
- pain management
- patient reported outcomes
- chronic pain
- hepatitis c virus
- drug induced
- adverse drug
- antiretroviral therapy